+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-Generation Sequencing Data Analysis Market - Global Forecast 2026-2032- Product Image
Next-Generation Sequencing Data Analysis Market - Global Forecast 2026-2032- Product Image
Sale

Next-Generation Sequencing Data Analysis Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5460259
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Next-Generation Sequencing Data Analysis Market is projected to reach USD 1.24 Billion in 2026. It is expected to continue growing at a CAGR of 12.06%, reaching USD 2.46 Billion by 2032.

Next-generation sequencing data analysis has become a core growth engine for precision medicine, clinical diagnostics, pharmaceutical discovery, population genomics, and translational research. As sequencing costs have declined dramatically since the early Human Genome Project era, the industry bottleneck has shifted from generating reads to managing, aligning, annotating, interpreting, securing, and operationalizing genomic data at scale.

Demand is strongest where organizations need reliable NGS bioinformatics pipelines, reproducible variant calling, compliant cloud infrastructure, and clinically defensible interpretation. Executive priorities now center on faster turnaround times, higher analytical accuracy, data interoperability, and the ability to connect genomic evidence with electronic health records, real-world evidence, and multi-omics datasets.

Transformative Shifts in the NGS Data Analysis Landscape

The NGS data analysis landscape is being reshaped by the migration from research-only workflows to regulated clinical and enterprise-grade environments. Laboratories are standardizing pipelines around quality control, alignment, variant calling, copy number analysis, structural variant detection, and annotation, while healthcare systems increasingly require audit trails, workflow validation, and secure data exchange.

Cloud bioinformatics, workflow orchestration, containerization, and open data standards are accelerating scalability and reproducibility. At the same time, long-read sequencing, single-cell sequencing, spatial genomics, liquid biopsy, and metagenomics are expanding analytical complexity. These shifts are increasing demand for platforms that can process diverse data types without compromising accuracy, compliance, or cost efficiency.

Cumulative Impact of Artificial Intelligence on NGS Analytics

Artificial intelligence is materially improving NGS data analysis by enhancing base calling, read mapping support, variant prioritization, phenotype matching, and interpretation workflows. Deep learning tools have demonstrated strong performance in small-variant calling, while AI-assisted annotation helps reduce manual review burden for clinical laboratories and research teams.

The cumulative impact of AI is not limited to speed. Machine learning enables pattern recognition across large genomic and multi-omics datasets, supporting oncology biomarker discovery, rare disease diagnosis, pharmacogenomics, infectious disease surveillance, and patient stratification. However, adoption depends on explainability, bias control, validation, cybersecurity, and alignment with regulatory expectations for clinical decision support.

Key Regional Insights Across Global NGS Data Analysis Markets

North America remains a leading region for NGS data analysis because of mature sequencing infrastructure, strong clinical genomics adoption, established cloud ecosystems, and major investments from health systems, academic centers, and life sciences organizations. The United States anchors regional demand through clinical oncology, rare disease diagnostics, public health genomics, and regulated laboratory workflows, while Canada contributes through population health initiatives, academic genomics networks, and public health sequencing capacity.

Europe is driven by national genomics programs, GDPR-governed data frameworks, and strong adoption in oncology, rare disease, reproductive health, and public health sequencing. Asia-Pacific is expanding as China, Japan, India, South Korea, Australia, and ASEAN markets invest in precision medicine, biobanks, hospital-based sequencing, and infectious disease genomics. Latin America shows rising demand in Brazil and Mexico as laboratories modernize oncology, pathogen surveillance, and agricultural genomics capabilities. The Middle East is building capacity through national genome initiatives, digital health modernization, and hereditary disease programs, while Africa is strengthening NGS data analysis through pathogen genomics networks, antimicrobial resistance monitoring, tuberculosis and malaria surveillance, and growing academic genomics collaborations.

Key Group Insights for NGS Data Analysis Adoption

The European Union is shaping NGS data analysis through coordinated research funding, cross-border health data ambitions, GDPR-aligned privacy requirements, and efforts to enable secure genomic data sharing across member states. G7 countries lead in clinical-grade genomics, AI governance, pharmaceutical R&D integration, public health sequencing, and standards-based data infrastructure, while NATO members increasingly recognize pathogen genomics, biosecurity analytics, and resilient health data systems as strategic capabilities.

BRICS markets are expanding sequencing capacity through population-scale research, domestic biotechnology investment, infectious disease monitoring, agricultural genomics, and growing clinical demand. ASEAN countries are adopting NGS in infectious disease surveillance, oncology, newborn screening, and academic research at varying levels of infrastructure maturity, creating demand for scalable and cost-efficient bioinformatics. The GCC is investing in national genome programs, digital health platforms, and precision medicine initiatives, creating demand for secure, scalable, and culturally representative genomic data analysis systems that support both clinical and population health use cases.

Key Country Insights in Next-Generation Sequencing Data Analysis

The United States leads in clinical genomics, oncology testing, cloud bioinformatics, public health sequencing, and regulatory-aware analytical validation, while Canada emphasizes research networks, public health genomics, indigenous and population health considerations, and equitable access. Mexico and Brazil are building stronger NGS capabilities for oncology, infectious disease, reproductive health, rare disease research, and agricultural genomics, supported by regional laboratory modernization and academic medical center adoption.

In Europe, the United Kingdom benefits from national genomic medicine infrastructure and health-system-linked sequencing, Germany and France invest heavily in precision medicine, clinical research, and translational genomics, Italy and Spain expand oncology and rare disease testing, and Russia maintains academic, agricultural, and public health sequencing capacity. China is a major sequencing and bioinformatics hub with extensive population genomics, oncology, and infectious disease capabilities. India is scaling cost-efficient genomics, diagnostics, newborn screening, and pathogen surveillance, while Japan focuses on precision oncology, pharmacogenomics, and aging-related research. Australia supports national genomic medicine initiatives, rare disease programs, and public health sequencing, and South Korea advances hospital-based genomics, biobanking, precision oncology, and AI-enabled healthcare analytics.

Actionable Recommendations for NGS Data Analysis Leaders

Industry leaders should prioritize validated, modular NGS bioinformatics pipelines that can support short-read, long-read, single-cell, spatial, metagenomic, liquid biopsy, and multi-omics workflows. Investment should focus on interoperability with laboratory information management systems, electronic health records, curated knowledge bases, secure cloud environments, and standardized data exchange frameworks.

Organizations should also strengthen data governance, model validation, cyber resilience, quality management, and compliance readiness. Strategic differentiation will come from reducing turnaround time, improving variant interpretation quality, expanding ancestry-aware reference datasets, supporting reproducible workflows, and building partnerships with hospitals, biopharma organizations, public health agencies, and academic genome centers.

Research Methodology for Verified NGS Intelligence

This executive summary is built on a structured research methodology combining secondary research, market intelligence, technology trend assessment, regulatory review, and industry validation. Sources typically include public health agencies, national genomics program disclosures, peer-reviewed literature, regulatory guidance, clinical practice developments, technical documentation, standards organizations, and expert perspectives.

Insights are triangulated across demand indicators, technology adoption patterns, regional policy environments, funding signals, infrastructure readiness, and end-user workflows. The methodology emphasizes verifiable evidence, consistency checks, and practical relevance for decision-makers evaluating NGS data analysis platforms, services, infrastructure, and partnerships, while avoiding unverified sizing or forecasting claims.

Conclusion: The Future of NGS Data Analysis

The next phase of next-generation sequencing data analysis will be defined by the convergence of clinical utility, AI-enabled interpretation, cloud scalability, and secure genomic data exchange. As sequencing becomes more embedded in routine healthcare, the value chain will increasingly reward analytics providers that deliver trusted results, workflow efficiency, reproducibility, and regulatory confidence.

Organizations that align bioinformatics innovation with clinical evidence, privacy protection, ancestry-aware interpretation, and global interoperability will be best positioned to capture opportunities across precision medicine, oncology, rare disease diagnostics, public health surveillance, infectious disease monitoring, pharmacogenomics, and multi-omics research worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Next-Generation Sequencing Data Analysis Market, by Product Type
7.1. Introduction
7.2. Services
7.2.1. Data Analysis Services
7.2.2. Bioinformatics Consulting Services
7.2.3. Cloud-based Analysis Services
7.3. Software
8. Next-Generation Sequencing Data Analysis Market, by Workflow Stage
8.1. Introduction
8.2. Primary Analysis
8.2.1. Base Calling
8.2.2. Signal Processing
8.2.3. Demultiplexing
8.3. Secondary Analysis
8.3.1. Read Mapping
8.3.2. Sequence Alignment
8.3.3. Variant Calling
8.3.3.1. SNP Detection
8.3.3.2. Indel Detection
8.4. Tertiary Analysis
8.4.1. Variant Annotation
8.4.2. Functional Analysis
8.4.3. Pathway Analysis
9. Next-Generation Sequencing Data Analysis Market, by Sequencing Type
9.1. Introduction
9.2. Whole Genome Sequencing
9.3. Whole Exome Sequencing
9.4. Targeted Sequencing
9.5. RNA Sequencing
9.6. Epigenomic Sequencing
10. Next-Generation Sequencing Data Analysis Market, by Automation Level
10.1. Introduction
10.2. Manual Analysis
10.3. Semi-automated Analysis
10.4. Fully Automated Analysis
11. Next-Generation Sequencing Data Analysis Market, by Application
11.1. Introduction
11.2. Clinical Diagnostics
11.2.1. Oncology
11.2.2. Rare Diseases
11.2.3. Infectious Diseases
11.2.4. Reproductive Health
11.2.5. Genetic Screening
11.3. Drug Discovery & Development
11.3.1. Target Identification
11.3.2. Biomarker Discovery
11.3.3. Pharmacogenomics
11.4. Agriculture & Animal Research
11.5. Forensic Genomics
12. Next-Generation Sequencing Data Analysis Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Government & Public Health Laboratories
12.4. Contract Research Organization
12.5. Hospitals & Clinics
12.6. Pharmaceutical & Biotechnology Companies
13. Next-Generation Sequencing Data Analysis Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Next-Generation Sequencing Data Analysis Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Next-Generation Sequencing Data Analysis Market, by Country
15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. 10x Genomics Inc
17.2. Agilent Technologies Inc
17.3. Basepair Inc
17.4. BGI Group
17.5. Bio-Rad Laboratories Inc
17.6. DNAnexus Inc
17.7. DNASTAR Inc
17.8. Element Biosciences Inc
17.9. Fabric Genomics Inc
17.10. Genscript Biotech Corp
17.11. Golden Helix Inc
17.12. Illumina Inc
17.13. MedGenome Inc
17.14. MGI Tech Co Ltd
17.15. Novogene Co Ltd
17.16. Oxford Nanopore Technologies PLC
17.17. Pacific Biosciences of California Inc
17.18. Psomagen Inc
17.19. QIAGEN
17.20. Revvity Inc
17.21. SOPHiA GENETICS SA
17.22. Takara Bio Inc
17.23. Thermo Fisher Scientific Inc
17.24. Twist Bioscience Corp
List of Figures
FIGURE 1. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BIOINFORMATICS CONSULTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BIOINFORMATICS CONSULTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BIOINFORMATICS CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CLOUD-BASED ANALYSIS SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CLOUD-BASED ANALYSIS SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CLOUD-BASED ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PRIMARY ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PRIMARY ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL PRIMARY ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL BASE CALLING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL BASE CALLING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL BASE CALLING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SIGNAL PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SIGNAL PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SIGNAL PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DEMULTIPLEXING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DEMULTIPLEXING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL DEMULTIPLEXING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SECONDARY ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SECONDARY ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SECONDARY ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL READ MAPPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL READ MAPPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL READ MAPPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SEQUENCE ALIGNMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SEQUENCE ALIGNMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SEQUENCE ALIGNMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL VARIANT CALLING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL VARIANT CALLING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL VARIANT CALLING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SNP DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SNP DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SNP DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL INDEL DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL INDEL DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL INDEL DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TERTIARY ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TERTIARY ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TERTIARY ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL VARIANT ANNOTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL VARIANT ANNOTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL VARIANT ANNOTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL FUNCTIONAL ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL FUNCTIONAL ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL FUNCTIONAL ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PATHWAY ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PATHWAY ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PATHWAY ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL RNA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL RNA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL EPIGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL EPIGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL EPIGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MANUAL ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL MANUAL ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL MANUAL ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SEMI-AUTOMATED ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL SEMI-AUTOMATED ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SEMI-AUTOMATED ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL FULLY AUTOMATED ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL FULLY AUTOMATED ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL FULLY AUTOMATED ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL RARE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL RARE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL RARE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL GENETIC SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL GENETIC SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL GENETIC SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL GOVERNMENT & PUBLIC HEALTH LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL GOVERNMENT & PUBLIC HEALTH LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL GOVERNMENT & PUBLIC HEALTH LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 159. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 160. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 161. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 162. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 163. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 164. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 165. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 166. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 168. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 169. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 199. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 200. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 201. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 202. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 203. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 204. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 205. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 206. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 207. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 208. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 209. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 210. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 211. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 216. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 222. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 224. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 225. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 230. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 231. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 232. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 233. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 234. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 235. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 236. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 237. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 238. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 239. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 240. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 243. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 244. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 245. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 246. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 247. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 248. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 249. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 250. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 251. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 253. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 254. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 256. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 257. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 258. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 259. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 260. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 261. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 262. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 263. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 264. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 265. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 266. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 267. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 268. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 284. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 285. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 286. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 287. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 288. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 289. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 290. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 291. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 292. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 293. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 294. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 295. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 296. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 297. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 298. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 299. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 300. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 301. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 302. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 303. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2017-2032 (USD MILLION)
TABLE 304. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2017-2032 (USD MILLION)
TABLE 305. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2017-2032 (USD MILLION)
TABLE 306. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 307. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 309. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 310. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 312. CHINA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. CHINA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 314. CHINA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 315. CHINA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2017-2032 (USD MILLION)
TABLE 316. CHINA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 201

Companies Mentioned

  • 10x Genomics Inc
  • Agilent Technologies Inc
  • Basepair Inc
  • BGI Group
  • Bio-Rad Laboratories Inc
  • DNAnexus Inc
  • DNASTAR Inc
  • Element Biosciences Inc
  • Fabric Genomics Inc
  • Genscript Biotech Corp
  • Golden Helix Inc
  • Illumina Inc
  • MedGenome Inc
  • MGI Tech Co Ltd
  • Novogene Co Ltd
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc
  • Psomagen Inc
  • QIAGEN
  • Revvity Inc
  • SOPHiA GENETICS SA
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience Corp

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.24 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.46 Billion
Compound Annual Growth Rate12.0%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Next Generation Sequencing Market - Global Forecast 2026-2032 - Product Image

Next Generation Sequencing Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Next-Generation Sequencing Sample Preparation Market - Global Forecast 2026-2032 - Product Image

Next-Generation Sequencing Sample Preparation Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Clinical Oncology Next Generation Sequencing - Global Strategic Business Report - Product Image

Clinical Oncology Next Generation Sequencing - Global Strategic Business Report

  • Report
  • 462 Pages
  • Global
From
Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report - Product Image

Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report

  • Report
  • 206 Pages
  • Global
From
Next Generation Sequencing Market Size, Share, Trends and Forecast by Sequencing Type, Product Type, Technology, Application, End-User, and Region, 2026-2034 - Product Image

Next Generation Sequencing Market Size, Share, Trends and Forecast by Sequencing Type, Product Type, Technology, Application, End-User, and Region, 2026-2034

  • Report
  • 142 Pages
  • Global
From

About the Next Generation Sequencing Data Analysis Market

The Next Generation Sequencing Data Analysis market within the Biotechnology industry is a rapidly growing sector. It is driven by the need to analyze large amounts of data generated from sequencing technologies, such as whole genome sequencing, transcriptome sequencing, and epigenetic sequencing. This data is used to identify genetic variants, gene expression patterns, and other biological information. The analysis of this data is essential for the development of new drugs, diagnostics, and treatments. The market is also driven by the increasing demand for personalized medicine, which requires the analysis of large amounts of data to identify individualized treatments. Additionally, the development of new sequencing technologies has enabled the analysis of larger datasets, which has further increased the demand for data analysis services. Companies in the Next Generation Sequencing Data Analysis market include Illumina, BGI, Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences, and 10X Genomics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.